Compare Airbnb, Inc. (ABNB) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Airbnb, Inc. vs Viatris Inc — how do they compare? Airbnb, Inc. trades at $180.49 (market cap $110.76B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Airbnb, Inc. is far larger — about 5.9× Viatris Inc's market cap, and Viatris Inc pays a 2.95% dividend while Airbnb, Inc. pays none. Which is the better fit depends on your goals.
| ABNB | VTRS | |
|---|---|---|
Market Cap | $110.76B | $18.69B |
Sector | Consumer Cyclical | Health |
52-Week High | $184.98 | $17.86 |
52-Week Low | $111.54 | $9.49 |
Enterprise Value | $101.19B | $30.80B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABNB trades at $179.40, down 2.87% over 24 hours, with a bullish technical outlook from moving averages but overbought RSI signals. The company reported Q2 2026 EPS of $1.37, beating expectations, and revenue growth continues with a 20.45% net income margin. Recent news highlights AI-driven growth and expansion into hotels and travel services.
Outlook is positive with strong analyst support and AI integration boosting efficiency, but high valuation ratios and competitive pressures pose risks. The consensus price target is $173.26, slightly below current price, indicating cautious optimism amid growth momentum.
Viatris (VTRS) trades at $16.105, down 1.07% on the day, with a bearish technical signal and mixed fundamentals. Recent Q2 2026 earnings beat estimates with EPS of $0.69 and revenue growth of 5%, but the company posted a net loss of $3.51B in 2025. Positive developments include FDA approval for Gwyn Lo and a raised 2026 outlook, though debt remains elevated at $14.04B long-term.
Outlook is cautious; while operational cash flow is strong at $2.32B and dividends provide income, persistent net losses and high P/E of 236.2 signal overvaluation risks. Analyst consensus leans Hold (61.54%), with upside potential if turnaround gains traction, but investors face headwinds from generic drug pricing pressures and execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Airbnb, Inc.
Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.
Read more on ABNB →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
